Management of Weakness and Numbness of Upper Left Extremity
Treat this as acute ischemic stroke until proven otherwise—immediately activate stroke protocols, obtain non-contrast head CT within 25 minutes, and prepare for IV alteplase if the patient presents within 4.5 hours of last known well and meets eligibility criteria. 1
Immediate Emergency Assessment (First 15 Minutes)
Time is brain—every 15-minute delay in treatment increases in-hospital mortality by 5%. 1
Critical Initial Steps
Stabilize airway, breathing, and circulation while simultaneously beginning stroke evaluation—do not delay assessment for stabilization unless the airway is compromised. 1, 2
Determine the exact time of last known well (when patient was last seen at baseline without symptoms)—this is zero-hour for all treatment decisions and determines thrombolysis eligibility. 1, 2
Obtain fingerstick glucose immediately to rule out hypoglycemia as a stroke mimic. 1, 2
Calculate NIHSS score to quantify stroke severity and guide treatment intensity. 1, 2
Monitor oxygen saturation with pulse oximetry and maintain target ≥92%; administer supplemental oxygen only if hypoxemic (saturation <94%). 3
Diagnostic Imaging Protocol
Obtain non-contrast head CT within 25 minutes of arrival to exclude hemorrhage and identify early ischemic changes—this is the single most critical diagnostic step. 1, 2
CT interpretation must occur within 45 minutes (door-to-interpretation time) for thrombolytic candidates. 1, 2
Add CT angiography if considering endovascular thrombectomy to identify large vessel occlusion. 1
Emergency treatment should NOT be delayed to obtain multimodal imaging studies (Class III recommendation). 3
Essential Laboratory Tests
Blood glucose, electrolytes, renal function, PT/INR, aPTT, complete blood count—obtain during initial evaluation but do not delay imaging or treatment. 2
12-lead ECG due to high incidence of cardiac disease in stroke patients. 2
Blood Pressure Management
Permissive hypertension is recommended unless thrombolysis is planned or BP exceeds 220/120 mmHg—aggressive lowering jeopardizes penumbral perfusion. 1
If Thrombolysis is Planned
Reduce BP to <185/110 mmHg BEFORE starting alteplase (Class I, Level B). 1
Maintain BP ≤180/105 mmHg during and for 24 hours after alteplase infusion (Class I, Level B). 1
If Thrombolysis is NOT Planned
Do not treat BP unless systolic ≥220 mmHg or diastolic ≥120 mmHg (Class III, Level A)—lowering BP in the first 48-72 hours does not reduce death or dependency and may worsen outcomes. 1
If BP is ≥220/120 mmHg, consider modest reduction of approximately 15% during first 24 hours, though benefit is uncertain (Class IIb, Level C). 1
Thrombolytic Therapy Decision
IV alteplase 0.9 mg/kg (maximum 90 mg) is the single most critical intervention for acute ischemic stroke and must be administered within 3-4.5 hours of symptom onset if eligible. 1, 2
Dosing Protocol
10% as bolus over 1 minute, remaining 90% infused over 60 minutes. 1
Treatment within 90 minutes of onset is most likely to result in favorable outcomes—every 30-minute delay reduces probability of favorable outcome by 10.6%. 1
Monitoring During Thrombolysis
NIHSS every 15 minutes during infusion, then hourly for 6 hours, then every 2 hours for 18 hours. 4
Maintain strict BP control ≤180/105 mmHg throughout infusion and for 24 hours after. 1, 4
Antiplatelet Therapy
Start aspirin 325 mg within 24-48 hours after stroke onset, but NEVER within 24 hours of alteplase. 1
If thrombolysis given, wait 24 hours and obtain repeat head CT to exclude hemorrhage before starting aspirin (Class I, Level A). 1, 4
Aspirin is NOT a substitute for IV alteplase in patients who meet thrombolysis criteria—do not delay alteplase to give aspirin. 1
Clopidogrel alone or combined with aspirin is NOT recommended for acute ischemic stroke (Class III, Level C). 1
Anticoagulation
Do NOT use full-dose unfractionated heparin or low-molecular-weight heparin for acute ischemic stroke—they do not improve outcomes and increase hemorrhage risk (Class III, Level A). 1
- Emergency anticoagulation does not lower risk of early recurrent stroke, even with cardioembolic sources (Class III, Level B). 1
Hospital Admission and Monitoring
Admit to dedicated stroke unit with continuous monitoring for at least 24 hours—stroke unit care reduces mortality and morbidity comparably to alteplase itself. 1, 4
Initial Management
Keep patient NPO until formal swallowing assessment completed—perform bedside swallowing screen within 24 hours before allowing any oral intake. 4
Monitor temperature every 4 hours for first 48 hours; treat fever aggressively if >37.5°C (99.5°F) with acetaminophen and cooling measures, as hyperthermia worsens neurological damage. 3, 4
Begin intermittent pneumatic compression devices within 24 hours for VTE prophylaxis in immobile patients. 1, 4
Start early mobilization within 24 hours if no contraindications—frequent brief out-of-bed activity involving sitting, standing, and walking. 3, 4
Repeat Imaging
- Repeat non-contrast head CT at 24 hours (or sooner if neurological deterioration) to assess for hemorrhagic transformation, especially if thrombolysis given. 4
Differential Diagnosis Considerations
While stroke is the primary concern, consider:
Guillain-Barré syndrome if weakness is bilateral, ascending, with areflexia and no sensory level—though this typically presents over days, not acutely. 3
Seizure with Todd's paralysis—obtain history of witnessed seizure activity. 3
Hypoglycemia—already ruled out with fingerstick glucose. 1
Critical Pitfalls to Avoid
Never aggressively lower BP in acute stroke unless giving thrombolytics or BP >220/120 mmHg—permissive hypertension maintains penumbral perfusion. 1
Never give aspirin within 24 hours of alteplase—this increases hemorrhage risk. 1
Never delay alteplase for "minor" symptoms—early treatment is critical even for seemingly mild deficits. 1
Never give oral medications, food, or water before swallowing assessment—aspiration pneumonia significantly worsens outcomes. 4
Never use vascular imaging to delay treatment in patients within 3-hour window (Class III, Level B). 3